Invesco S&P 500 Equal Weight Health Care ETF Rating $28.93 -0.20 (-0.69%) Closing price 09/15/2025 04:10 PM EasternExtended Trading$28.93 +0.00 (+0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco S&P 500 Equal Weight Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RSPH Aggregate RatingModerate Buy 2.57Holdings in RSPH have an aggregate rating of Moderate Buy based on 1,048 analyst ratings issued in the past year covering 61 companies (100.1% of the portfolio).RSPH Aggregate Price Target$28.93High Prediction$28.93Average Prediction$28.93Low Prediction$28.93Holdings in RSPH have an aggregate price target of $28.93 and a range of $28.93 to $28.93 covering 61 companies (100.1% of the portfolio).RSPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy38 Moderate Buy rating(s)Hold19 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P 500 Equal Weight Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 61 RSPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.80%CNCCentene$32.66-1.8%4.8561 of 5 stars2.12$38.33 17.4%17Gap Down1.78%PFEPfizer$23.98+0.5%4.9867 of 5 stars2.39$28.12 17.3%18Positive News1.77%WSTWest Pharmaceutical Services$257.73+1.7%4.9782 of 5 stars2.90$318.56 23.6%10News CoveragePositive NewsAnalyst Forecast1.74%BDXBecton, Dickinson and Company$185.90-0.5%4.9523 of 5 stars2.36$211.44 13.7%11Positive News1.73%EWEdwards Lifesciences$76.10-1.9%4.7317 of 5 stars2.67$86.26 13.4%24Positive NewsAnalyst DowngradeShort Interest ↑1.72%BMYBristol Myers Squibb$46.34+0.3%4.8906 of 5 stars2.24$56.38 21.7%21Positive News1.72%ABBVAbbVie$217.92-0.2%4.7651 of 5 stars2.92$218.76 0.4%26Trending NewsAnalyst ForecastAnalyst Revision1.72%GILDGilead Sciences$112.54-1.8%4.9215 of 5 stars2.89$115.39 2.5%27Positive News1.71%CAHCardinal Health$150.45-1.2%4.9551 of 5 stars2.79$165.93 10.3%14Positive News1.70%ABTAbbott Laboratories$131.40-1.7%4.9208 of 5 stars2.91$144.47 9.9%22Positive News1.69%BSXBoston Scientific$99.75-2.9%4.8269 of 5 stars3.08$118.04 18.3%26Positive News1.69%LHLabcorp$275.33-0.9%4.7027 of 5 stars2.62$290.33 5.5%13Positive News1.69%MCKMcKesson$702.38-1.3%4.638 of 5 stars2.85$725.10 3.2%13Positive News1.69%MRKMerck & Co., Inc.$81.07-2.1%4.9979 of 5 stars2.35$107.44 32.5%20Positive News1.68%ZBHZimmer Biomet$100.90-2.1%4.799 of 5 stars2.39$111.00 10.0%18Positive News1.68%DXCMDexCom$75.58-0.8%4.9768 of 5 stars2.91$99.89 32.2%22Positive News1.67%DVADaVita$130.95-1.7%4.6487 of 5 stars1.75$158.00 20.7%4Analyst Upgrade1.67%IQVIQVIA$186.20-0.5%4.9425 of 5 stars2.75$229.64 23.3%24Positive News1.67%JNJJohnson & Johnson$177.49-0.3%4.6867 of 5 stars2.65$176.29 -0.7%20Positive NewsAnalyst Upgrade1.67%STESTERIS$247.71-0.9%4.9143 of 5 stars2.75$273.50 10.4%8Positive NewsAnalyst Upgrade1.66%TMOThermo Fisher Scientific$474.73-1.0%4.9755 of 5 stars2.77$592.24 24.8%22Positive News1.66%LLYEli Lilly and Company$748.26-0.9%4.9972 of 5 stars2.68$941.35 25.8%22Trending News1.66%DHRDanaher$188.24-1.0%4.9895 of 5 stars2.85$246.35 30.9%20Positive NewsDividend Announcement1.66%ISRGIntuitive Surgical$433.99-3.5%4.9481 of 5 stars2.60$595.95 37.3%20Positive News1.65%VTRSViatris$9.60-3.6%1.6375 of 5 stars1.80$10.40 8.3%5High Trading Volume1.65%DGXQuest Diagnostics$180.71-1.2%4.7707 of 5 stars2.50$186.00 2.9%18Positive News1.65%CORCencora$292.33-3.4%4.8406 of 5 stars2.75$311.25 6.5%12Positive News1.65%SYKStryker$377.49-1.5%4.9614 of 5 stars2.78$431.42 14.3%18Positive News1.65%TFXTeleflex$125.75-3.5%4.6675 of 5 stars2.00$141.57 12.6%10Analyst Downgrade1.64%MTDMettler-Toledo International$1,262.22+0.2%4.1476 of 5 stars2.50$1,311.11 3.9%10Positive News1.64%MDTMedtronic$93.48-0.6%4.9509 of 5 stars2.63$102.14 9.3%19Positive News1.64%MOHMolina Healthcare$176.34-2.5%4.7764 of 5 stars2.23$225.18 27.7%13Short Interest ↑Gap Down1.64%WATWaters$299.46+1.4%4.7641 of 5 stars2.47$378.73 26.5%15Trending News1.63%PODDInsulet$340.29-0.4%4.4799 of 5 stars2.89$335.12 -1.5%18Positive News1.62%AAgilent Technologies$125.68+2.0%4.5616 of 5 stars2.50$140.08 11.5%12Analyst ForecastAnalyst Revision1.62%GEHCGE HealthCare Technologies$77.76+1.7%4.2434 of 5 stars2.91$88.40 13.7%11Positive News1.62%AMGNAmgen$274.40-0.7%4.665 of 5 stars2.24$304.43 10.9%21Positive News1.62%BIIBBiogen$143.32-1.1%4.6921 of 5 stars2.32$181.65 26.7%31Positive News1.62%HOLXHologic$63.80-1.0%4.9325 of 5 stars2.59$78.00 22.3%17Positive NewsAnalyst Downgrade1.62%CRLCharles River Laboratories International$152.47-0.3%4.6177 of 5 stars2.31$177.07 16.1%16Positive NewsAnalyst Upgrade1.62%ELVElevance Health$306.87-1.6%4.8913 of 5 stars2.67$411.06 34.0%18Positive News1.62%HCAHCA Healthcare$403.40-0.4%4.5673 of 5 stars2.53$403.17 -0.1%17Positive News1.62%RVTYRevvity$84.06+1.4%4.1406 of 5 stars2.71$120.07 42.8%14Positive News1.61%UNHUnitedHealth Group$348.05-1.3%4.9067 of 5 stars2.52$358.95 3.1%25Trending NewsShort Interest ↓1.61%INCYIncyte$83.14+0.0%4.7357 of 5 stars2.33$82.53 -0.7%18Positive NewsAnalyst DowngradeShort Interest ↓1.60%CICigna Group$297.31-1.8%5 of 5 stars3.00$374.76 26.1%19Positive NewsAnalyst Upgrade1.60%IDXXIDEXX Laboratories$643.99+0.4%4.2447 of 5 stars2.80$649.44 0.8%10Positive News1.60%TECHBio-Techne$51.62+0.7%4.9902 of 5 stars2.77$70.42 36.4%13Positive News1.60%SOLVSolventum$73.19-0.3%2.1415 of 5 stars2.27$85.44 16.8%11Analyst Forecast1.60%RMDResMed$271.39+0.5%4.5966 of 5 stars2.82$278.36 2.6%17Positive News1.60%UHSUniversal Health Services$189.65-1.1%4.9341 of 5 stars2.21$214.77 13.2%14Positive NewsAnalyst Downgrade1.59%BAXBaxter International$23.78-0.9%4.8889 of 5 stars2.20$30.11 26.6%10News CoveragePositive News1.58%MRNAModerna$23.88+1.6%4.5366 of 5 stars2.05$41.81 75.1%221.57%COOCooper Companies$65.48-1.8%4.4592 of 5 stars2.92$86.64 32.3%12Positive News1.57%ZTSZoetis$146.34-1.3%4.8248 of 5 stars2.56$200.88 37.3%9Positive News1.56%REGNRegeneron Pharmaceuticals$572.59+2.2%4.7091 of 5 stars2.82$817.67 42.8%28Positive NewsShort Interest ↑1.55%HSICHenry Schein$68.81-0.3%3.8355 of 5 stars2.42$76.67 11.4%121.55%HUMHumana$274.75-0.6%4.4447 of 5 stars2.30$289.24 5.3%23Positive News1.49%ALGNAlign Technology$131.06-0.4%4.946 of 5 stars2.50$215.00 64.0%16Positive News1.47%VRTXVertex Pharmaceuticals$393.21-0.3%4.9011 of 5 stars2.57$496.05 26.2%28Positive News1.45%CVSCVS Health$73.50-2.0%4.9558 of 5 stars2.96$77.89 6.0%24Positive NewsAnalyst Downgrade This page (NYSEARCA:RSPH) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P 500 Equal Weight Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P 500 Equal Weight Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RSPH Stock Alerts